These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 14619756)

  • 41. Calcium and vitamin D--for whom and when.
    Prince RL
    Menopause Int; 2007 Mar; 13(1):35-7. PubMed ID: 17448266
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Strontium: new drug. Postmenopausal osteoporosis: too many unknowns.
    Prescrire Int; 2005 Dec; 14(80):207-11. PubMed ID: 16397977
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Teriparatide (human recombinant 1-34 parathyroid hormone)--a new treatment regimen for severe osteoporosis].
    Vestergaard P; Nielsen LR; Mosekilde L
    Ugeskr Laeger; 2004 Aug; 166(32):2653-5. PubMed ID: 15347166
    [No Abstract]   [Full Text] [Related]  

  • 44. [Rational and results of weekly treatment with calcidiol in postmenopausal and senile osteoporosis].
    Rossini M; Viapiana O; Idolazzi L; Fracassi E; Gatti D; Adami S
    Minerva Med; 2007 Feb; 98(1):53-68. PubMed ID: 17372582
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [The influence of hormonal replacement therapy on bone density in postmenopausal women depending on polymorphism of vitamin D receptor (VDR) and estrogen receptor (ER) genes].
    Brodowska A
    Ann Acad Med Stetin; 2003; 49():111-30. PubMed ID: 15552843
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Food labeling: health claims; calcium and osteoporosis, and calcium, vitamin D, and osteoporosis. Final rule.
    Food and Drug Administration, HHS
    Fed Regist; 2008 Sep; 73(189):56477-87. PubMed ID: 18985959
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [The role of vitamin D in the treatment of osteoporosis in the elderly].
    Pfeifer M; Minne HW
    Med Klin (Munich); 2006 Jun; 101 Suppl 1():15-9. PubMed ID: 16826364
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Mayo Clinic office visit. Learning more about osteopenia.
    Hurley D
    Mayo Clin Womens Healthsource; 2005 Apr; 9(4):S1-2. PubMed ID: 15891675
    [No Abstract]   [Full Text] [Related]  

  • 49. [Men also need bone protection].
    MMW Fortschr Med; 2006 Nov; 148(46):48-9. PubMed ID: 17615790
    [No Abstract]   [Full Text] [Related]  

  • 50. Association of bone metabolism related genes polymorphisms with the effect of raloxifene hydrochloride on bone mineral density and bone turnover markers in postmenopausal women with osteoporosis.
    Zhang ZL; He JW; Qin YJ; Huang QR; Liu YJ; Hu YQ; Li M
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2006 Apr; 23(2):129-33. PubMed ID: 16604479
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Influence of the selective oestrogen receptor modulator (raloxifene hydrochloride) on IL-6, TNF-alpha, TGF-beta1 and bone turnover markers in the treatment of postmenopausal osteoporosis.
    Ozmen B; Kirmaz C; Aydin K; Kafesciler SO; Guclu F; Hekimsoy Z
    Eur Cytokine Netw; 2007 Sep; 18(3):148-53. PubMed ID: 17823083
    [TBL] [Abstract][Full Text] [Related]  

  • 52. What is adequate?
    Jones AB
    Can Fam Physician; 2006 Sep; 52(9):1059; author reply 1059-60. PubMed ID: 17279209
    [No Abstract]   [Full Text] [Related]  

  • 53. [Osteoporosis--treatment with Calcium/Vitamin D].
    Z Orthop Ihre Grenzgeb; 2005; 143(3):278. PubMed ID: 15977113
    [No Abstract]   [Full Text] [Related]  

  • 54. Osteodensitometry in healthy postmenopausal women.
    Prescrire Int; 2008 Apr; 17(94):68-72. PubMed ID: 18536138
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Non-response to osteoporosis treatment.
    Francis RM
    J Br Menopause Soc; 2004 Jun; 10(2):76-80. PubMed ID: 15207030
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Physical activity, smoking and the significance of vitamins A and D in osteoporosis].
    Eiken PA; Schwarz P; Nielsen LR
    Ugeskr Laeger; 2005 Feb; 167(9):1018-20. PubMed ID: 15803996
    [No Abstract]   [Full Text] [Related]  

  • 57. [Medical prophylaxis and treatment of steroid induced osteoporosis].
    Rødevand E; Mikkelsen K; Nordvåg BY; Haga HJ; Førre Ø; Johnsen V; Kvien TK
    Tidsskr Nor Laegeforen; 2005 Jun; 125(12):1643-5. PubMed ID: 15976829
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Osteoporosis treatment in 2005.
    Adler RA
    South Med J; 2005 Oct; 98(10):963. PubMed ID: 16295807
    [No Abstract]   [Full Text] [Related]  

  • 59. Anabolic therapy for osteoporosis.
    Bilezikian JP
    Int J Fertil Womens Med; 2005; 50(2):53-60. PubMed ID: 16334411
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Drugs for prevention and treatment of postmenopausal osteoporosis.
    Treat Guidel Med Lett; 2002 Nov; 1(3):13-8. PubMed ID: 15529101
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.